DDOOD Financials 07/16/2014 04:08:57 Cerebain Bio

DDOOD Financials 07/16/2014 04:08:57
Cerebain Biotech Corp.
Period Ending Jun 30, 2013 Jun 30, 2012 Nov 30, 2011 Jun 30, 2011
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 109 4 - -
Sales, General and Admin. 1,223 944 16 7
Non-Recurring Items - - - -
Other - 1 - -
Operating Income (1,332) (949) (16) (7)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (1,332) (949) (16) (7)
Interest Expense - - - -
Earnings Before Tax (1,332) (949) (16) (7)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,332) (949) (16) (7)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,332) (949) (16) (7)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,332) (949) (16) (7)